Abstract
The term ‘scurvy’ for the disease resulting from prolonged vitamin C deficiency had origins in ‘scorbutus’ (Latin), ‘scorbut’ (French), and ‘Skorbut’ (German). Scurvy was a common problem in the world’s navies and is estimated to have affected 2 million sailors. In 1747, James Lind conducted a trial of six different treatments for 12 sailors with scurvy: only oranges and lemons were effective in treating scurvy. Scurvy also occurred on land, as many cases occurred with the ‘great potato famine’ in Ireland in 1845. Many animals, unlike humans, can synthesize their own vitamin C. Axel Holst and Theodor Frölich fortuitously produced scurvy in the guinea pig, which like humans requires vitamin C in the diet. In 1928, Albert Szent-Györgyi isolated a substance from adrenal glands that he called ‘hexuronic acid’. Four years later, Charles Glen King isolated vitamin C in his laboratory and concluded that it was the same as ‘hexuronic acid’. Norman Haworth deduced the chemical structure of vitamin C in 1933.
References
1.
Wagner HR: Spanish Voyages to the North West Coast of America in the Sixteenth Century. San Francisco, California Historical Society, 1929.
2.
Carpenter KJ: The History of Scurvy and Vitamin C. Cambridge, UK, Cambridge University Press, 1986.
3.
Lind J: A Treatise of the Scurvy. Edinburgh, Millar, 1753, p 223 [also republished with original pagination by Stewart CP and Guthrie D (eds): Lind’s Treatise on Scurvy. A Bicentenary Volume. Edinburgh, Edinburgh University Press, 1953].
4.
Elliotson J: Clinical lecture. Lancet 1831;1:649–655.
5.
Christison R: Account of scurvy as it has lately appeared in Edinburgh, and of an epidemic of it among railway labourers. Monthly J Med Sci 1847;8:1–22.
6.
Foltz JM: Report on scorbutus, as it appeared on board the United States squadron, blockading the ports in the Gulf of Mexico in the summer of 1846. Am J Med Sci 1848;29:38–57 (new series).
7.
von Liebig J: Animal Chemistry. London, Taylor and Walton, 1842.
8.
Anderson A: On the recent difference of opinion as to the cause of scurvy. Monthly J Med Sci 1847;8:176–181.
9.
Curran JO: Observations on scurvy as it has lately appeared throughout Ireland, and in several parts of Great Britain. Dublin Q J Med Sci 1847;4:83–134.
10.
Garrod AB: On the nature, cause and prevention of scurvy. Monthly J Med Sci (London, Edinburgh) 1848;8:457–463.
11.
Hammond WA: Scurvy, Report of a Committee of the Sanitary Committee, Washington, ed 2. Washington, DC, McGill and Witherow, 1865.
12.
Holst A, Frölich T: Experimental studies relating to ship-beri-beri and scurvy. I. J Hyg (Cambridge) 1907;7:634–671.
13.
Szent-Gyorgyi A: Observations on the function of the peroxidase systems and the chemistry of the adrenal cortex. Description of a new carbohydrate derivative. Biochem J 1928;22:1387–1409.
14.
King CG, Waugh WA: The chemical nature of vitamin C. Science 1932;75:357–358.
15.
Svirbely JL, Szent-Gyorgyi A: Hexuronic acid as the antiscorbutic factor. Nature 1932;129:576.
16.
Reichstein T, Grussner A, Oppenheimer R: Synthese der d- und l-Ascorbinsäure (C-vitamin). Helv Chim Acta 1933;16:1019–1033.
17.
Herbert RW, Hirst EL, Percival EGB, Reynolds RJW, Smith F: The constitution of ascorbic acid. J Chem Soc (London) 1933;[no volume]:1270–1290.
18.
Pauling L: Vitamin C, the Common Cold and the Flu. San Francisco, WH Freeman, 1976.
19.
Sherlock P, Rothschild EO: Scurvy produced by a Zen macrobiotic diet. JAMA 1967;199:794–798.
20.
McCord CP: Scurvy as an occupational disease. J Occup Med 1971;13:306–307, 348–351, 393–395, 441–447, 484–491, 586–592.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
